Particle.news

Download on the App Store

MSU Pinpoints β-1,6-Glucan’s Role in Candida auris Antifungal Resistance

The findings chart a path to targeted antifungal therapies by revealing how C. auris remodels its cell wall to withstand frontline drugs.

Image

Overview

  • Advanced solid-state NMR with dynamic nuclear polarization showed that caspofungin treatment stiffens polysaccharides in both Candida species but C. auris preserves wall architecture by upregulating β-1,6-glucan rather than thickening its wall.
  • Deletion of C. auris’ KRE6a and KRE6b genes confirmed that β-1,6-glucan synthases are essential for echinocandin resistance, with loss of KRE6b markedly increasing caspofungin susceptibility.
  • Comparative analysis revealed that C. albicans responds to echinocandins by thickening its wall and boosting chitin content, whereas C. auris maintains cell wall thickness through selective β-1,6-glucan reinforcement.
  • An international, multidisciplinary team leveraged cutting-edge NMR techniques and gene deletion approaches to achieve high-resolution mapping of intact fungal cell wall dynamics under drug pressure.
  • Insights from the Nature Communications study provide a strategic framework for designing species-specific antifungal agents that target C. auris’ unique cell wall adaptations.